{
  "gene_analysis_summary": {
    "gene": "TP53",
    "cell_type": "epithelial_cell",
    "regulatory_role": "hub_regulator",
    "analysis_depth": "comprehensive"
  },
  "network_analysis": {
    "gene": "TP53",
    "ensembl_id": "ENSG00000141510",
    "cell_type": "epithelial_cell",
    "gene_info": null,
    "network_available": true,
    "in_network": true,
    "is_regulator": true,
    "regulatory_role": "hub_regulator",
    "num_regulators": 7,
    "num_targets": 163,
    "regulators": [
      "ENSG00000157110",
      "ENSG00000111642",
      "ENSG00000167157",
      "ENSG00000030419",
      "ENSG00000126351",
      "ENSG00000137693",
      "ENSG00000018408"
    ],
    "targets": [
      "ENSG00000284753",
      "ENSG00000273899",
      "ENSG00000244734",
      "ENSG00000235162",
      "ENSG00000217128",
      "ENSG00000215252",
      "ENSG00000214194",
      "ENSG00000213654",
      "ENSG00000205544",
      "ENSG00000205502"
    ],
    "network_position": {
      "in_degree": 7,
      "out_degree": 163,
      "role": "hub_regulator"
    }
  },
  "regulatory_analysis": {
    "gene": "TP53",
    "cell_type": "epithelial_cell",
    "regulator_summary": {
      "total_regulators": 7,
      "analyzed_regulators": 7
    },
    "hub_regulators": [
      {
        "gene_symbol": "RBPMS",
        "ensembl_id": "ENSG00000157110",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "CHD4",
        "ensembl_id": "ENSG00000111642",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "PRRX2",
        "ensembl_id": "ENSG00000167157",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "IKZF2",
        "ensembl_id": "ENSG00000030419",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "THRA",
        "ensembl_id": "ENSG00000126351",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "YAP1",
        "ensembl_id": "ENSG00000137693",
        "regulatory_strength": "moderate"
      },
      {
        "gene_symbol": "WWTR1",
        "ensembl_id": "ENSG00000018408",
        "regulatory_strength": "moderate"
      }
    ]
  },
  "target_analysis": {
    "gene": "TP53",
    "cell_type": "epithelial_cell",
    "target_summary": {
      "total_targets": 10,
      "analyzed_targets": 10
    },
    "cascade_targets": [
      {
        "gene_symbol": "EEF1AKMT4",
        "ensembl_id": "ENSG00000284753",
        "cascade_level": 1
      },
      {
        "gene_symbol": "NOL12",
        "ensembl_id": "ENSG00000273899",
        "cascade_level": 1
      },
      {
        "gene_symbol": "HBB",
        "ensembl_id": "ENSG00000244734",
        "cascade_level": 1
      },
      {
        "gene_symbol": "C12ORF75",
        "ensembl_id": "ENSG00000235162",
        "cascade_level": 1
      },
      {
        "gene_symbol": "FNIP1",
        "ensembl_id": "ENSG00000217128",
        "cascade_level": 1
      },
      {
        "gene_symbol": "GOLGA8B",
        "ensembl_id": "ENSG00000215252",
        "cascade_level": 1
      },
      {
        "gene_symbol": "SMIM30",
        "ensembl_id": "ENSG00000214194",
        "cascade_level": 1
      },
      {
        "gene_symbol": "GPSM3",
        "ensembl_id": "ENSG00000213654",
        "cascade_level": 1
      },
      {
        "gene_symbol": "TMEM256",
        "ensembl_id": "ENSG00000205544",
        "cascade_level": 1
      },
      {
        "gene_symbol": "C2CD4B",
        "ensembl_id": "ENSG00000205502",
        "cascade_level": 1
      }
    ]
  },
  "pathway_enrichment": {
    "status": "success",
    "analysis_type": "reactome_pathway_enrichment",
    "genes_analyzed": [
      "GOLGA8B",
      "C2CD4B",
      "TMEM256",
      "YAP1",
      "C12ORF75",
      "IKZF2",
      "FNIP1",
      "SMIM30",
      "WWTR1",
      "CHD4",
      "PRRX2",
      "EEF1AKMT4",
      "GPSM3",
      "RBPMS",
      "HBB",
      "NOL12",
      "THRA",
      "TP53"
    ],
    "genes_recognized": 0,
    "token": "MjAyNTEwMjUxNTE2MDVfMTczMzc%3D",
    "enriched_pathways": [
      {
        "pathway_id": "R-HSA-6804754",
        "pathway_name": "Regulation of TP53 Expression",
        "p_value": 1.4206272860750602e-05,
        "fdr": 0.0033384741222763914,
        "genes_found": 2,
        "genes_total": 4,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8951671",
        "pathway_name": "RUNX3 regulates YAP1-mediated transcription",
        "p_value": 7.162223497303444e-05,
        "fdr": 0.00837980149184503,
        "genes_found": 2,
        "genes_total": 9,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-2032785",
        "pathway_name": "YAP1- and WWTR1 (TAZ)-stimulated gene expression",
        "p_value": 0.00028436358707972786,
        "fdr": 0.019899192467899063,
        "genes_found": 2,
        "genes_total": 18,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8878159",
        "pathway_name": "Transcriptional regulation by RUNX3",
        "p_value": 0.00042226754659924204,
        "fdr": 0.019899192467899063,
        "genes_found": 3,
        "genes_total": 108,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-2028269",
        "pathway_name": "Signaling by Hippo",
        "p_value": 0.00042338707378508644,
        "fdr": 0.019899192467899063,
        "genes_found": 2,
        "genes_total": 22,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9819196",
        "pathway_name": "Zygotic genome activation (ZGA)",
        "p_value": 0.0005893896705315704,
        "fdr": 0.022986197150731247,
        "genes_found": 2,
        "genes_total": 26,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8940973",
        "pathway_name": "RUNX2 regulates osteoblast differentiation",
        "p_value": 0.0010012484123187448,
        "fdr": 0.028958115634214465,
        "genes_found": 2,
        "genes_total": 34,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-6804758",
        "pathway_name": "Regulation of TP53 Activity through Acetylation",
        "p_value": 0.0013119552241748211,
        "fdr": 0.028958115634214465,
        "genes_found": 2,
        "genes_total": 39,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9723907",
        "pathway_name": "Loss of Function of TP53 in Cancer",
        "p_value": 0.0013653145863551375,
        "fdr": 0.028958115634214465,
        "genes_found": 1,
        "genes_total": 1,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9723905",
        "pathway_name": "Loss of function of TP53 in cancer due to loss of tetramerization ability",
        "p_value": 0.0013653145863551375,
        "fdr": 0.028958115634214465,
        "genes_found": 1,
        "genes_total": 1,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9619665",
        "pathway_name": "EGR2 and SOX10-mediated initiation of Schwann cell myelination",
        "p_value": 0.001378957887343546,
        "fdr": 0.028958115634214465,
        "genes_found": 2,
        "genes_total": 40,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8941326",
        "pathway_name": "RUNX2 regulates bone development",
        "p_value": 0.0015896141572677713,
        "fdr": 0.0290345056690402,
        "genes_found": 2,
        "genes_total": 43,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-5633007",
        "pathway_name": "Regulation of TP53 Activity",
        "p_value": 0.0017771167063241888,
        "fdr": 0.0290345056690402,
        "genes_found": 3,
        "genes_total": 178,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-6806003",
        "pathway_name": "Regulation of TP53 Expression and Degradation",
        "p_value": 0.0018146566043150125,
        "fdr": 0.0290345056690402,
        "genes_found": 2,
        "genes_total": 46,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8853884",
        "pathway_name": "Transcriptional Regulation by VENTX",
        "p_value": 0.001972622685470715,
        "fdr": 0.029589340282060728,
        "genes_found": 2,
        "genes_total": 48,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-983231",
        "pathway_name": "Factors involved in megakaryocyte development and platelet production",
        "p_value": 0.00226842786493453,
        "fdr": 0.03175799010908342,
        "genes_found": 3,
        "genes_total": 194,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-8943724",
        "pathway_name": "Regulation of PTEN gene transcription",
        "p_value": 0.003894140463024831,
        "fdr": 0.050623826019322804,
        "genes_found": 2,
        "genes_total": 68,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9909649",
        "pathway_name": "Regulation of PD-L1(CD274) transcription",
        "p_value": 0.0045888996274326965,
        "fdr": 0.05947490683481105,
        "genes_found": 2,
        "genes_total": 74,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-9925563",
        "pathway_name": "Developmental Lineage of Pancreatic Ductal Cells",
        "p_value": 0.004956242236234254,
        "fdr": 0.05947490683481105,
        "genes_found": 2,
        "genes_total": 77,
        "species": "Homo sapiens"
      },
      {
        "pathway_id": "R-HSA-69560",
        "pathway_name": "Transcriptional activation of p53 responsive genes  ",
        "p_value": 0.008165239708599836,
        "fdr": 0.08165239708599836,
        "genes_found": 1,
        "genes_total": 6,
        "species": "Homo sapiens"
      }
    ],
    "summary": {
      "total_pathways": 20,
      "significant_pathways": 16
    }
  },
  "perturbation_analysis": {
    "target_gene": "TP53",
    "cell_type": "epithelial_cell",
    "baseline_regulators": 7,
    "perturbation_results": [
      {
        "regulator": "RBPMS",
        "regulator_ensembl_id": "ENSG00000157110",
        "impact_score": 0.486,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 403,
        "cascade_overlap": 1,
        "affected_cascades": [
          "PCDH20",
          "DUSP14",
          "NBPF19",
          "ATF7-NPFF",
          "KLF14"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "RBPMS is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "CHD4",
        "regulator_ensembl_id": "ENSG00000111642",
        "impact_score": 0.486,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 243,
        "cascade_overlap": 2,
        "affected_cascades": [
          "SLURP2",
          "LHX1",
          "POM121C",
          "PECAM1",
          "CEP95"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "CHD4 is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "IKZF2",
        "regulator_ensembl_id": "ENSG00000030419",
        "impact_score": 0.486,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 112,
        "cascade_overlap": 0,
        "affected_cascades": [
          "MSANTD7",
          "SYNRG",
          "PECAM1",
          "ARFGAP3",
          "AQP1"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "IKZF2 is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "YAP1",
        "regulator_ensembl_id": "ENSG00000137693",
        "impact_score": 0.486,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 207,
        "cascade_overlap": 1,
        "affected_cascades": [
          "CCL4",
          "PECAM1",
          "HMBS",
          "ZNF345",
          "CD302"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "YAP1 is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "WWTR1",
        "regulator_ensembl_id": "ENSG00000018408",
        "impact_score": 0.486,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 293,
        "cascade_overlap": 1,
        "affected_cascades": [
          "CCL4L2",
          "NCOA4",
          "TMEM141",
          "ARHGEF38",
          "C12ORF75"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "WWTR1 is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "PRRX2",
        "regulator_ensembl_id": "ENSG00000167157",
        "impact_score": 0.458,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 93,
        "cascade_overlap": 1,
        "affected_cascades": [
          "MARCKS",
          "RASSF5",
          "HBB",
          "OR5H14",
          "TNF"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "PRRX2 is a hub regulator - high therapeutic impact but may have off-target effects"
      },
      {
        "regulator": "THRA",
        "regulator_ensembl_id": "ENSG00000126351",
        "impact_score": 0.41,
        "regulatory_loss_pct": 14.3,
        "regulator_downstream_targets": 81,
        "cascade_overlap": 0,
        "affected_cascades": [
          "CD302",
          "VPS52",
          "JPT2",
          "RAD54B",
          "MAPT"
        ],
        "therapeutic_potential": "high",
        "druggability_notes": "THRA is a hub regulator - high therapeutic impact but may have off-target effects"
      }
    ],
    "therapeutic_insights": {
      "summary": "Identified 7 potential therapeutic targets for TP53",
      "top_target": {
        "regulator": "RBPMS",
        "impact_score": 0.486,
        "therapeutic_potential": "high"
      },
      "high_impact_targets": 7,
      "strategy": "Inhibiting RBPMS would reduce TP53 regulation by 14.3% and affect 403 downstream genes",
      "recommendation": "Priority: RBPMS is a high-impact therapeutic target for modulating TP53. Consider small molecule inhibitors or targeted therapies."
    },
    "summary": "Analyzed 7 regulatory perturbations for TP53"
  },
  "cross_cell_comparison": {
    "gene": "TP53",
    "cell_type_analysis": {
      "epithelial_cell": {
        "regulatory_role": "hub_regulator",
        "num_regulators": 7,
        "num_targets": 163,
        "in_network": true
      },
      "cd14_monocytes": {
        "regulatory_role": "regulator",
        "num_regulators": 1,
        "num_targets": 1,
        "in_network": true
      },
      "cd16_monocytes": {
        "regulatory_role": "regulator",
        "num_regulators": 1,
        "num_targets": 1,
        "in_network": true
      },
      "cd20_b_cells": {
        "regulatory_role": "regulator",
        "num_regulators": 0,
        "num_targets": 1,
        "in_network": true
      },
      "cd4_t_cells": {
        "regulatory_role": "target",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "cd8_t_cells": {
        "regulatory_role": "target",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "erythrocytes": {
        "regulatory_role": "hub_regulator",
        "num_regulators": 1,
        "num_targets": 41,
        "in_network": true
      },
      "nk_cells": {
        "regulatory_role": "target",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "nkt_cells": {
        "regulatory_role": "hub_regulator",
        "num_regulators": 4,
        "num_targets": 28,
        "in_network": true
      },
      "monocyte-derived_dendritic_cells": {
        "regulatory_role": "target",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "hepatocytes": {
        "regulatory_role": "unknown",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "cardiomyocytes": {
        "regulatory_role": "unknown",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "neurons": {
        "regulatory_role": "unknown",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "fibroblasts": {
        "regulatory_role": "unknown",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      },
      "endothelial_cells": {
        "regulatory_role": "unknown",
        "num_regulators": 0,
        "num_targets": 0,
        "in_network": false
      }
    },
    "summary": "Cross-cell analysis completed"
  },
  "similarity_analysis": null,
  "domain_analysis": {
    "cancer_analysis": {
      "gene": "TP53",
      "domain": "cancer_research",
      "insights": {
        "oncogenic_potential": "high",
        "tumor_suppressor_likelihood": "moderate",
        "therapeutic_target_score": 0.9,
        "mutation_impact": "high"
      },
      "cancer_pathways": [],
      "biomarker_potential": "high",
      "research_priority": "high",
      "summary": "TP53 shows high oncogenic potential with moderate tumor suppressor likelihood"
    },
    "drug_analysis": {
      "gene": "TP53",
      "domain": "drug_development",
      "insights": {
        "druggability_score": 0.95,
        "target_class": "kinase",
        "intervention_strategy": "inhibition",
        "development_complexity": "high"
      },
      "cascade_effects": [],
      "clinical_trial_readiness": "ready",
      "development_timeline": "3-5 years",
      "summary": "TP53 has 95.0% druggability score with inhibition strategy recommended"
    },
    "clinical_analysis": {
      "gene": "TP53",
      "domain": "clinical_relevance",
      "insights": {
        "disease_association_likelihood": "moderate",
        "biomarker_utility": "prognostic",
        "clinical_actionability": "moderate"
      },
      "tissue_specificity": [
        "Broadly expressed across 6 cell types"
      ],
      "diagnostic_potential": "moderate",
      "summary": "TP53 shows moderate disease association with prognostic biomarker utility"
    },
    "systems_analysis": {
      "gene": "TP53",
      "domain": "systems_biology",
      "insights": {
        "network_centrality": 1.0,
        "regulatory_hierarchy": "hub",
        "information_flow": "moderate",
        "network_vulnerability": "critical"
      },
      "network_effects": [],
      "perturbation_impact": "system-wide",
      "evolutionary_conservation": "high",
      "summary": "TP53 has 100.0% network centrality with critical vulnerability level"
    }
  },
  "workflow_metadata": {
    "start_time": 93672.39,
    "steps_completed": [
      "gene_network_analysis",
      "targets_analysis",
      "regulators_analysis",
      "perturbation_analysis",
      "pathway_analysis",
      "cross_cell_analysis",
      "cancer_domain_analysis",
      "drug_domain_analysis",
      "clinical_domain_analysis",
      "systems_domain_analysis"
    ],
    "total_analysis_time": 297.0000000059372
  },
  "key_insights": {
    "regulatory_role": "hub_regulator",
    "regulation_strength": "moderate",
    "regulatory_influence": "high",
    "cell_type_specificity": "high",
    "cancer_relevance": "unknown",
    "therapeutic_potential": 0,
    "druggability": 0,
    "drug_development_priority": "unknown",
    "clinical_significance": "unknown",
    "biomarker_potential": "unknown",
    "network_importance": "unknown",
    "systems_complexity": "unknown"
  }
}